甘草干姜汤通过PD-1/TGF-β1/IL-17A通路抗博来霉素诱导的特发性肺纤维化
本研究探讨甘草干姜汤对博来霉素诱导的小鼠特发性肺纤维化的治疗作用及机制。结果表明甘草干姜汤可增加体重、降低肺指数、改善肺部炎症与纤维化,并抑制上皮-间质转化和细胞外基质沉积。其作用机制与调节PD-1/TGF-β1/IL-17A通路相关。
要点
- 甘草干姜汤可改善博来霉素诱导的小鼠肺纤维化与炎症。
- 其机制涉及下调PD-1、p-STAT3、IL-17A和TGF-β1。
- 甘草干姜汤抑制上皮-间质转化和细胞外基质沉积。
核心结论
- 甘草干姜汤通过调节PD-1/TGF-β1/IL-17A通路对特发性肺纤维化发挥治疗作用。
研究设计与样本
- 采用博来霉素诱导的特发性肺纤维化小鼠模型,给予甘草干姜汤灌胃。
主要发现
- 甘草干姜汤可增加小鼠体重并降低肺指数。
- 甘草干姜汤显著改善小鼠肺组织炎症并减轻特发性肺纤维化。
- 甘草干姜汤降低肺组织PD-1含量及外周血CD4+ T细胞PD-1表达。
- 甘草干姜汤降低p-STAT3、IL-17A和TGF-β1含量。
- 甘草干姜汤通过增加E-cadherin表达、降低vimentin和α-SMA表达抑制上皮-间质转化,减少细胞外基质沉积。
临床怎么用
- 甘草干姜汤作为传统中药方剂,在动物模型中显示抗肺纤维化潜力,可为临床治疗特发性肺纤维化提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Firstly prescribed in the ancient Chinese book Jingui Yaolue, Gancao Ganjiang decoction (GGD) is a traditional Chinese herbal formula that has been widely used to treat "atrophic lung disease". GGD is a popular and widely used traditional Chinese medicine. The decoction is extracted from the dried rhizomes and roots of Glycyrrhiza uralensis Fisch. and Zingiber officinale Roscoe (2:1). AIM OF STUDY: To investigate the therapeutic effect of idiopathic pulmonary fibrosis (IPF) of GGD, a bleomycin-induced IPF murine model was used in this study. MATERIALS AND METHODS: Mice were induced by bleomycin instillation and GGD was orally administered. Changes on mice weight were recorded during the experiment. Lung weight was recorded on days 14 and 28, and pulmonary index was calculated accordingly. Pathological evaluation, including fibrosis analysis of lung tissue, was assessed by H&E and Masson staining. The expression of PD-1, p-STAT3 and IL-17A were detected by immunohistochemistry (IHC). The expression of p-STAT3 in lung tissues of mice were detected by Western blot. The level of IL-17A in lung tissue were detected by ELISA. The expression of PD-1 in CD4+ T cells in peripheral blood of mice was detected by flow cytometry. The levels of hydroxyproline and TGF-β1 in lung tissue were detected by ELISA. The expression of E-cadherin, vimentin and α-SMA in lung tissues of mice were detected by qRT-PCR and Western blot. RESULTS: GGD can increase body weight and reduce pulmonary index in mice with pulmonary fibrosis. As such, GGD can significantly improve the inflammatory and alleviate IPF in the lung tissue of mice. GGD treatment was capable of reducing the content of PD-1 in lung tissue as well as the expression of PD-1 in CD4+ T cells in peripheral blood. Likewise, GGD was able to reduce the content of p-STAT3, IL-17A and TGF-β1. In addition, GGD stimulation could inhibit epithelial-mesenchymal transformation (EMT) by increasing the expression of E-cadherin and reducing vimentin and α-SMA, thus reducing extracellular matrix (ECM) deposition. CONCLUSION: Our results indicate that GGD positively affects IPF by regulating PD-1/TGF-β1/IL-17A pathway.
引用
- Wang D, Gong L, Li Z, et al. Antifibrotic effect of Gancao Ganjiang decoction is mediated by PD-1 / TGF-β1 / IL-17A pathway in bleomycin-induced idiopathic pulmonary fibrosis. J Ethnopharmacol. 2021. PMID: 34391863. doi:10.1016/j.jep.2021.114522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。